Masimo | MASI - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Accuray USD 53.42M 8.45M 2025-12
Align Technology USD 4.15B 100.27M 2026-03
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 491.69M 242K 2026-03
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
General Electric Aerospace USD 18.06B 841M 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
Masimo USD 788.9M 67.7M 2026-03
Medtronic USD 48.99B 128M 2025-12
Orthofix International USD 435.19M 14.85M 2026-03
Owens Minor USD -464.76M 3.79M 2026-03
ResMed USD 6.49B 171.03M 2026-03
Steris USD 7.18B 29.1M 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03